Bringing AI-driven protein-design tools to biologists everywhere
Artificial intelligence is already proving it can accelerate drug development and improve our understanding of disease. But to turn AI into novel treatments we need to get the latest, most powerful models into the hands of scientists. The problem is that most scientists aren’t machine-learning experts. Now the company OpenProtein.AI is helping scientists stay on…